Skip to main content
Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.6840
-1.2460 (-64.56%)
At close: Nov 11, 2026, 4:00 PM EST
0.6834
-0.0006 (-0.09%)
After-hours: Nov 11, 2026, 7:59 PM EST

Basel Medical Group Financials Overview

Millions SGD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
21.5121.5111.3510.059.7510.66
Revenue Growth
45.99%89.45%12.97%3.12%-8.55%-
Gross Profit
8.348.342.44.164.167.94
Operating Income
-0.79-0.79-2.142.222.46
Net Income
-0.75-0.75-10.642.071.781.98
Earnings Per Share
-0.78-0.78-6.791.531.321.46
EPS Growth
---16.23%-9.84%-

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
0.530.539.822.041.311.66
Total Debt
9.629.626.535.717.2110.15
Net Cash (Debt)
-9.09-9.093.29-3.67-5.9-8.49
Net Cash Growth
------
Net Cash Per Share
-5.75-5.752.10-2.71-4.36-6.27

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-0.64-0.64-4.042.512.62.79
Capital Expenditures
-0.25-0.25-0.56-0.01-0.01-0.09
Free Cash Flow
-0.88-0.88-4.62.52.592.7
Free Cash Flow Growth
----3.56%-4.07%-

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
38.77%38.77%21.18%41.43%42.71%74.48%
Operating Margin
-3.67%-3.67%-18.85%21.84%20.55%23.09%
Pretax Margin
-5.81%-5.81%-97.35%23.92%21.87%22.39%
Profit Margin
-3.48%-3.48%-93.67%20.62%18.30%18.56%
FCF Margin
-4.11%-4.11%-40.52%24.89%26.61%25.37%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
0.060.653.75---